622
Views
2
CrossRef citations to date
0
Altmetric
Commentary - Commissioned

Ras-ling with new therapeutic targets for metastasis

&
Pages 249-253 | Received 22 Feb 2017, Accepted 20 Mar 2017, Published online: 04 May 2017

Figures & data

Figure 1. Oncogenic Ras promotes productive metabolism and blocks anoikis via divergent downstream effectors. During ECM-detachment, cells harboring oncogenic Ras mutations signal via a PI(3)K/SGK1-mediated pathway to increase glucose uptake, ATP generation, and survival (right, green box). Simultaneously, oncogenic Ras diminishes PHLPP1 levels to overcome p38 MAPK-mediated anoikis activation (left, red box).

Figure 1. Oncogenic Ras promotes productive metabolism and blocks anoikis via divergent downstream effectors. During ECM-detachment, cells harboring oncogenic Ras mutations signal via a PI(3)K/SGK1-mediated pathway to increase glucose uptake, ATP generation, and survival (right, green box). Simultaneously, oncogenic Ras diminishes PHLPP1 levels to overcome p38 MAPK-mediated anoikis activation (left, red box).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.